Article Details

Nascent Biotech Opens Phase 1 Human Trial to Evaluate Pritumumab as Treatment Option for ...

Retrieved on: 2021-03-24 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Nascent Biotech Opens Phase 1 Human Trial to Evaluate Pritumumab as Treatment Option for .... View article details on hiswai:

Excerpt

... Company pioneering the development of monoclonal antibodies targeting ... PTB is a natural human antibody that works by binding to Cell surface ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo